← Back to Search

Optokinetic Stimulation

OKS for Hemisensory Neglect

N/A

Waitlist Available

Led By Chun Lim, MD

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after 1 hour of oks

Awards & highlights

Study Summary

This trial will help researchers understand how optokinetic stimulation (a therapy involving moving patterns) can help patients with hemispatial neglect (a disorder where patients have difficulty attending to objects on the left side following a stroke).

Eligible Conditions

Hemisensory Neglect
Sensory Neglect
Hemispatial Neglect

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after 1 hour of oks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after 1 hour of oks

This trial's timeline: 3 weeks for screening, Varies for treatment, and after 1 hour of oks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Hemispatial neglect scores

Effect of OKS on vision

Secondary outcome measures

Changes in secondary hemispatial neglect scores

Effect of OKS on gait

Trial Design

4Treatment groups

Experimental Treatment

Group I: Safety and efficacy studyExperimental Treatment1 Intervention

Randomized study assessing the safety and efficacy of OKS in treating hemispatial neglect

Group II: Optimization of OKSExperimental Treatment1 Intervention

Crossover study examining various OKS protocols on improving symptoms of hemispatial neglect

Group III: OKS and gaitExperimental Treatment1 Intervention

Effect of OKS on gait and balance

Group IV: Effect of repetitive stimulationExperimental Treatment1 Intervention

Benefits of daily, repetitive OKS in treating hemispatial neglect

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

OKS

2018

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Eye Institute (NEI)NIH

546 Previous Clinical Trials

1,401,916 Total Patients Enrolled

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,010,324 Total Patients Enrolled

Johns Hopkins UniversityOTHER

2,256 Previous Clinical Trials

14,820,059 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity to participate in this research endeavor?

"To register for this clinical trial, participants must suffer from sensory neglect and be within the age range of 21 to 80. The research team is looking for a total of 52 individuals to take part in the study."

Answered by AI

Does this research include individuals aged 70 and above?

"The parameters for inclusion in this study necessitate that individuals must be between 21 and 80 years old. There are also 2 trials specifically designed for minors and 12 clinical studies available to people aged 65 or above."

Answered by AI

Is enrollment available for this clinical experiment?

"According to the listing on clinicaltrials.gov, this medical study is actively recruiting participants and was originally posted in May 2018 with its latest update occurring on March 8th 2022."

Answered by AI

To what extent has enrollment for this clinical trial been successful?

"Affirmative. The resource on clinicaltrials.gov supports that this experiment, which was created on May 1st 2018, is actively recruiting volunteers. 52 individuals are needed to be enlisted from a single medical establishment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

OKS for the Treatment of Hemispatial Neglect

Chun Lim 2018. "OKS for the Treatment of Hemispatial Neglect". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03451708.